The angiotensin II receptor blocker candesartan mitigates cisplatin-induced myocardial injury via suppression of TLR-4/NF-κB/IRF-3/AP-1 signaling and restoration of antioxidant defenses. - Hassanein EHM; Abd El-Ghafar OAM; Alnasser SM; Alruhaimi RS; Althagafy HS; Atwa AM; Mahmoud AM (Tissue & cell, 2026)